ArticleEuropean journal of medicinal chemistry2022

ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders.

Stefania Demuro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.